• 1. 310. Tautomerism in the phthalazine series. The N- and O-derivatives of 1-methylphthalaz-4-one and phthalaz-1 : 4-dione
  F. M. Rowe,A. T. Peters J. Chem. Soc. 1933 1331

Professional Introduction to 1-Chloro-4-methylphthalazine (CAS No. 19064-68-7)

1-Chloro-4-methylphthalazine (CAS No. 19064-68-7) is a significant compound in the field of pharmaceutical chemistry, characterized by its unique structural and chemical properties. This heterocyclic aromatic compound belongs to the phthalazine class, which has garnered considerable attention due to its diverse biological activities and potential applications in medicinal chemistry.

The molecular structure of 1-Chloro-4-methylphthalazine consists of a phthalazine core substituted with a chlorine atom at the 1-position and a methyl group at the 4-position. This specific arrangement imparts distinct reactivity and functionality, making it a valuable intermediate in the synthesis of various pharmacologically active agents. The presence of both electron-withdrawing and electron-donating groups enhances its versatility in chemical transformations, facilitating the development of novel therapeutic compounds.

In recent years, 1-Chloro-4-methylphthalazine has been extensively studied for its potential in drug discovery and development. Its phthalazine scaffold is known to exhibit a range of biological activities, including antimicrobial, anti-inflammatory, and anticancer properties. Researchers have leveraged these characteristics to design and synthesize derivatives with enhanced efficacy and reduced toxicity.

One of the most compelling aspects of 1-Chloro-4-methylphthalazine is its role as a precursor in the synthesis of more complex molecules. The chlorine substituent at the 1-position allows for further functionalization through nucleophilic aromatic substitution reactions, enabling the introduction of various pharmacophores. Similarly, the methyl group at the 4-position can be modified through Friedel-Crafts alkylation or other coupling reactions, expanding the structural diversity of potential drug candidates.

The pharmaceutical industry has shown particular interest in derivatives of 1-Chloro-4-methylphthalazine due to their promising biological profiles. For instance, studies have demonstrated that certain phthalazine derivatives exhibit potent inhibitory effects on kinases and other enzymes involved in cancer progression. These findings have spurred further investigation into optimizing synthetic routes and exploring new applications.

The chemical reactivity of 1-Chloro-4-methylphthalazine also makes it a valuable tool in research laboratories. Its ability to undergo various transformations allows chemists to explore different reaction pathways and develop innovative synthetic strategies. This flexibility is particularly useful in drug discovery pipelines, where rapid and efficient synthesis of target compounds is essential.

In addition to its pharmaceutical applications, 1-Chloro-4-methylphthalazine has been investigated for its potential use in material science. The unique electronic properties of phthalazines make them suitable for applications in organic electronics, such as light-emitting diodes (LEDs) and organic photovoltaics. By incorporating this compound into advanced materials, researchers aim to develop more efficient and sustainable technologies.

The synthesis of 1-Chloro-4-methylphthalazine typically involves multi-step processes that require careful optimization to ensure high yields and purity. Common synthetic routes include chlorination of pre-existing phthalazine derivatives and alkylation reactions under controlled conditions. Advances in catalytic methods have further improved the efficiency of these processes, making it more feasible to produce large quantities for industrial applications.

Evaluation of the safety profile of 1-Chloro-4-methylphthalazine is crucial before considering its use in pharmaceutical formulations. Toxicological studies have been conducted to assess its acute and chronic effects on living organisms. These studies provide essential data for determining safe dosages and identifying potential side effects, ensuring that any therapeutic applications are both effective and safe for patients.

The future prospects for 1-Chloro-4-methylphthalazine are promising, with ongoing research aimed at uncovering new biological activities and expanding its utility in drug development. Collaborative efforts between chemists, biologists, and pharmacologists are expected to yield novel compounds with improved therapeutic properties. As our understanding of phthalazines continues to grow, so too will their role in addressing unmet medical needs.

• 1217472-17-7(1-chloro-4-methyl-6-Phthalazinol)
• 1121-79-5(3-Chloro-6-methylpyridazine)
• 10132-01-1(1-chloro-4-phenylphthalazine)
• 76972-35-5(1-chloro-4-(4-methylphenyl)phthalazine)
• 1237522-70-1(1-chloro-4-(trifluoromethyl)phthalazine)
• 1217472-10-0(4-chloro-6-methoxy-1-methylphthalazine)
• 345903-80-2(1,4-dichloro-6-methylphthalazine)
• 678193-44-7(1,4-Dichloro-5-methylphthalazine)
• 1217472-12-2(4-chloro-1-methyl-6-Phthalazinol)
• 1217472-14-4(1-chloro-6-methoxy-4-methyl-Phthalazine)